| Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? BM Ross, J Seguin, LE Sieswerda Lipids in health and disease 6, 1-19, 2007 | 396 | 2007 |
| One type of gamma-turn, rather than the other gives rise to chain-reversal in proteins EJ Milner-White, BM Ross, R Ismail, K Belhadj-Mostefa, R Poet Journal of molecular biology 204 (3), 777-782, 1988 | 236 | 1988 |
| Increased phospholipid breakdown in schizophrenia: evidence for the involvement of a calcium-independent phospholipase A2 BM Ross, C Hudson, J Erlich, JJ Warsh, SJ Kish Archives of general psychiatry 54 (5), 487-494, 1997 | 225 | 1997 |
| Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia BM Ross, S Turenne, A Moszczynska, JJ Warsh, SJ Kish Brain research 821 (2), 407-413, 1999 | 164 | 1999 |
| Phospholipid‐Metabolizing Enzymes in Alzheimer's Disease: Increased Lysophospholipid Acyltransferase Activity and Decreased Phospholipase A2 Activity BM Ross, A Moszczynska, J Erlich, SJ Kish Journal of neurochemistry 70 (2), 786-793, 1998 | 143 | 1998 |
| Hydrogen sulfide and asthma P Wang, G Zhang, T Wondimu, B Ross, R Wang Experimental physiology 96 (9), 847-852, 2011 | 114 | 2011 |
| Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder BM Ross, I McKenzie, I Glen, CPW Bennett Nutritional neuroscience 6 (5), 277-281, 2003 | 104 | 2003 |
| Omega-3 polyunsaturated fatty acids and anxiety disorders BM Ross Prostaglandins, Leukotrienes and Essential Fatty Acids 81 (5-6), 309-312, 2009 | 103 | 2009 |
| Phospholipid biosynthetic enzymes in human brain BM Ross, A Moszczynska, JK Blusztajn, A Sherwin, A Lozano, SJ Kish Lipids 32, 351-358, 1997 | 82 | 1997 |
| Biomarkers of oxidative stress in schizophrenic and control subjects J Young, SB McKinney, BM Ross, KWJ Wahle, SP Boyle Prostaglandins, leukotrienes and essential fatty acids 76 (2), 73-85, 2007 | 81 | 2007 |
| Robustness of G proteins in Alzheimer's disease: an immunoblot study M McLaughlin, BM Ross, G Milligan, J McCulloch, JT Knowler Journal of Neurochemistry 57 (1), 9-14, 1991 | 79 | 1991 |
| On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease BM Ross, JT Knowler, J McCulloch Journal of neurochemistry 58 (5), 1810-1819, 1992 | 78 | 1992 |
| Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease BM Ross, N Mamalias, A Moszczynska, AH Rajput, SJ Kish Neuroscience 102 (4), 899-904, 2001 | 72 | 2001 |
| ω− 3 Fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism BM Ross Medical hypotheses 68 (3), 515-524, 2007 | 71 | 2007 |
| Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders SJ Kish, I Lopes-Cendes, M Guttman, Y Furukawa, M Pandolfo, ... Archives of neurology 55 (10), 1299-1304, 1998 | 63 | 1998 |
| Characterization of a Novel Phospholipase A2 Activity in Human Brain BM Ross, DK Kim, JV Bonventre, SJ Kish Journal of neurochemistry 64 (5), 2213-2221, 1995 | 60 | 1995 |
| Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia C Hudson, A Gotowiec, M Seeman, J Warsh, BM Ross Biological psychiatry 46 (3), 401-405, 1999 | 59 | 1999 |
| Detection of acetone and isoprene in human breath using a combination of thermal desorption and selected ion flow tube mass spectrometry A Hryniuk, BM Ross International Journal of Mass Spectrometry 285 (1-2), 26-30, 2009 | 58 | 2009 |
| Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users J Tong, BM Ross, GA Schmunk, FJ Peretti, KS Kalasinsky, Y Furukawa, ... American Journal of Psychiatry 160 (5), 896-903, 2003 | 58 | 2003 |
| Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity A Fallbrook, SD Turenne, N Mamalias, SJ Kish, BM Ross Brain research 834 (1-2), 207-210, 1999 | 52 | 1999 |
Anna MoszczynskaDepartment of Pharmaceutical Sciences, Wayne State University在 wayne.edu 的电子邮件经过验证
